Urist Marshall

Urist Marshall, EVP, Research & Investments, has filed 12 insider trading reports covering 1 company. Total disclosed trading volume is $8.8M. Sales ($8.8M) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves Royalty Pharma plc (RPRX). All transactions sourced from SEC Form 4 filings.